Literature DB >> 28616683

General practitioners' perceptions of the current status and pharmacists' contribution to primary care in Iceland.

Anna Bryndis Blondal1, Jon Steinar Jonsson2, Sofia Kälvemark Sporrong3, Anna Birna Almarsdottir3.   

Abstract

Background For the past several years pharmacists' responsibilities have expanded globally from traditional tasks of dispensing medications to collaborating with other health care professionals in patient care. Similar developments have not occurred in outpatient settings in Iceland. Objective The aim of this study was to explore Icelandic general practitioners' views on the current status of primary care, their perceptions of pharmacists as a health care profession, and their attitudes towards future GP-pharmacist collaboration in primary care in Iceland. Setting Twelve primary care clinics in Iceland. Methods Semi-structured in-depth interviews were conducted with general practitioners from different primary care clinics in Iceland. A purposive and snowball sampling technique was used to select participants. All interviews were recorded and transcribed verbatim. The transcripts were categorized by themes and then analyzed using conventional content analysis. Main outcome measure General practitioners' attitudes towards pharmacists. Results Twenty general practitioners from twelve different primary care clinics in Iceland were interviewed. There are several unmet needs regarding medicines and patient monitoring in the Icelandic health care system. General practitioners suggested ways in which these gaps may be addressed and pharmacist-led clinical service was one of the suggestions. Currently, their communication with pharmacists in the primary sector solely surrounds practical non-clinical issues. Due to increasing polypharmacy and multimorbidity, they suggested that pharmacists should be more involved in patient care. Conclusions General practitioners believe that pharmacist-led clinical service can increase the quality of patient therapy. To improve communication between these health care providers, pharmacists must also re-professionalize (strengthening the profession´s status through new responsibilities and tasks), not having a conflict of interest and showing that they have expertise in patient care.

Entities:  

Keywords:  Attitudes; Collaboration; General practitioners; Pharmaceutical care; Pharmacist; Primary care

Mesh:

Year:  2017        PMID: 28616683     DOI: 10.1007/s11096-017-0478-7

Source DB:  PubMed          Journal:  Int J Clin Pharm


  25 in total

1.  Physician attitudes toward pharmacist provision of medication therapy management services.

Authors:  Fadi M Alkhateeb; Kevin A Clauson; Renee McCafferty; David A Latif
Journal:  Pharm World Sci       Date:  2009-05-27

2.  General practitioners' views of pharmacists' current and potential contributions to medication review and prescribing in New Zealand.

Authors:  Ernieda Hatah; Rhiannon Braund; Stephen B Duffull; June Tordoff
Journal:  J Prim Health Care       Date:  2013-09-01

3.  The challenge of integrating community pharmacists into the primary health care team: a case study of local pharmaceutical services (LPS) pilots and interprofessional collaboration.

Authors:  Fay Bradley; Rebecca Elvey; Darren M Ashcroft; Karen Hassell; Juliette Kendall; Bonnie Sibbald; Peter Noyce
Journal:  J Interprof Care       Date:  2008-08       Impact factor: 2.338

4.  [General practice in Iceland, the present situation].

Authors:  Halldor Jonsson
Journal:  Laeknabladid       Date:  2011-05       Impact factor: 0.548

5.  'Because of the circumstances, we cannot develop our role': Norwegian community pharmacists' perceived responsibility in role development.

Authors:  Karin Svensberg; Sofia Kälvemark Sporrong; Helle Håkonsen; Else-Lydia Toverud
Journal:  Int J Pharm Pract       Date:  2014-10-30

6.  Reprofessionalization in pharmacy.

Authors:  A Birenbaum
Journal:  Soc Sci Med       Date:  1982       Impact factor: 4.634

7.  [Medication use among community-dwelling older Icelanders. Population-based study in urban and rural areas].

Authors:  Arun K Sigurdardottir; Solveig Asa Arnadottir; Elín Díanna Gunnarsdottir
Journal:  Laeknabladid       Date:  2011-12       Impact factor: 0.548

8.  [Medication use in nursing homes in Iceland 2002-2004. A descriptive study].

Authors:  Helga Hansdóttir; Pétur G Guđmannsson
Journal:  Laeknabladid       Date:  2013-09       Impact factor: 0.548

Review 9.  The impact of pharmaceutical care practice on the practitioner and the patient in the ambulatory practice setting: twenty-five years of experience.

Authors:  Linda M Strand; Robert J Cipolle; Peter C Morley; Michael J Frakes
Journal:  Curr Pharm Des       Date:  2004       Impact factor: 3.116

10.  Physician perceptions of pharmacist-provided medication therapy management: qualitative analysis.

Authors:  Stephanie Harriman McGrath; Margie E Snyder; Gladys Garcia Dueñas; Janice L Pringle; Randall B Smith; Melissa Somma McGivney
Journal:  J Am Pharm Assoc (2003)       Date:  2010 Jan-Feb
View more
  4 in total

1.  Development and testing of a framework for defining a strategy to address medication adherence during patient encounters in community pharmacies.

Authors:  Pascal C Baumgartner; Nicolas Comment; Kurt E Hersberger; Isabelle Arnet
Journal:  Explor Res Clin Soc Pharm       Date:  2022-03-09

2.  General practitioners' attitude towards cooperation with other health professionals in managing patients with multimorbidity and polypharmacy: A cross-sectional study.

Authors:  Hélène Carrier; Anna Zaytseva; Aurélie Bocquier; Patrick Villani; Martin Fortin; Pierre Verger
Journal:  Eur J Gen Pract       Date:  2022-12       Impact factor: 3.636

3.  Exploring the current and future role of the pharmacists in osteoporosis screening and management in Malaysia.

Authors:  L S Toh; P S M Lai; S Othman; A Shah; C P L Dang; B Y Low; K T Wong; C Anderson
Journal:  Int J Clin Pharm       Date:  2018-01-29

4.  Introducing Pharmaceutical Care to Primary Care in Iceland-An Action Research Study.

Authors:  Anna Bryndis Blondal; Sofia Kälvemark Sporrong; Anna Birna Almarsdottir
Journal:  Pharmacy (Basel)       Date:  2017-04-26
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.